Article
Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids.
Molecular genetics & genomic medicine - 1 Mar 2021
Kim Sun Young, Ing Alexander, Gong Shunyou, Yap Kai Lee, Bhat Rukhmi
Abstract excerpt
BACKGROUND: Homozygous or compound heterozygous pathogenic variants in the thromboxane A synthase 1 (TBXAS1) gene are associated with Ghosal hematodiaphyseal dysplasia (GHDD) which is characterized by defective hematopoiesis and increased bone density of long bones. METHODS: Patients 1 and 2 are identical twins, who presented with red blood cell transfusion-dependent normocytic anemia and thrombocytopenia with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
